Erez Raphael bought $9,400 of DRIO
Chief Executive Officer at DarioHealth Corp.. 10,000 shares at an average of $0.94, traded Aug 20, 2024, filed Aug 23, 2024.
Score components
- +25RoleCEO
- 0Trade size$9k at market
- -5Relative to holdingsUnder 1% of holdings (0.5%)
- +8Price context73% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +7.5%, 3m -9.1%, 6m -25.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-092417, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 20, 2024 | POpen-market purchase Common Stock | +5,000 | $0.93 | $4,650 | 1,927,059 | Aug 23, 2024 |
| Aug 21, 2024 | POpen-market purchase Common Stock | +5,000 | $0.95 | $4,750 | 1,932,059 | Aug 23, 2024 |
Related signals
Other insiders at DarioHealth Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | DRIObuy DarioHealth Corp. | Dennis Matheis director | $100k 14,430 shares | +50% | |
| 38Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson President and CCO | $21k 40,000 shares | +73% | |
| 18Weak | DRIObuy DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $4,546 5,000 shares | +10% | |
| 52Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $8,244 10,000 shares | +25% | |
| 56Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $12k 15,000 shares | +60% | |
| 51Moderate | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $4,400 5,000 shares | +0% | |
| 46Moderate | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $14k 15,000 shares | +150% | |
| 36Weak | DarioHealth Corp. | Erez Raphael Chief Executive Officer | $8,980 10,000 shares | +1% | |
| 39Weak | DarioHealth Corp. | Steven Charles Nelson Chief Commercial Officer | $9,283 10,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.